Salarius Pharmaceuticals Inc

NASDAQ:SLRX   1:26:08 PM EDT
1.85
+0.28 (+17.83%)
Earnings Announcements

Salarius Pharmaceuticals Reports Third Quarter Results

Published: 11/10/2022 16:39 GMT
Salarius Pharmaceuticals Inc (SLRX) - Salarius Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update.
Net Loss for Q3 of 2022 Was $14.4 Million, Or $6.41 per Share.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$2.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.